Saturday, 8 April 2017

New Report Covers Global Botulinum Toxin Market 2017-2021

Report Global Botulinum Toxin Market 2017-2021 is a new market research publication announced by Reportstack. 
Report Outline: Botulinum toxin is a chemical substance, which is used as a drug to regulate the release of acetylcholine, the chemical that regulates the neuron flow in the nervous system to activate the muscles. To be used as a drug, botulinum toxin must be isolated, purified, and stabilized. This substance finds its place largely as one of the most sought-after muscle relaxants in the modern pharma industry for multiple indications such as cosmetic surgery, skeletal muscle relaxants, and neuromuscular relaxants to name a few.
For detailed report with TOC, please click here ​Global Botulinum Toxin Market 2017-2021
Market Growth: The global botulinum toxin market to grow at a CAGR of 8.16% during the period 2017-2021.
Key vendors • ALLERGAN
• Galderma
• Ipsen
• Merz Pharma
• Pfizer
Other prominent vendors • Acorda Therapeutics
• Aldeyra Therapeutics
• Azidus Brasil
• Biolab Sanus Farmaceutica
• Canbex Therapeutics
• Emcure Pharmaceuticals
• Endo Pharmaceuticals International
• Evolus
• Fresenius Kabi
• GlaxoSmithKline
• Johnson & Johnson
• Lannett
• Lanzhou Institute of Biological Products
• LEO Pharma
• Mylan
• Par Pharmaceuticals
• PhytoTech Therapeutics
• Revance Therapeutics
• Sun Pharmaceuticals
• Takeda Pharmaceutical
• UroGen Pharma
Regions Covered: 
• Americas
Companies Mentioned
ALLERGAN, Galderma, Ipsen, Merz Pharma, Pfizer, Acorda Therapeutics, Aldeyra Therapeutics, Azidus Brasil, Biolab Sanus Farmaceutica, Canbex Therapeutics, DAEWOONG, Emcure Pharmaceuticals, Endo Pharmaceuticals International, Evolus, Fresenius Kabi, GlaxoSmithKline, INSYS THERAPEUTICS, Johnson & Johnson, Lannett, Lanzhou Institute of Biological Products, LEO Pharma, Mylan, Par Pharmaceuticals, PhytoTech Therapeutics, Revance Therapeutics, Sun Pharmaceuticals, Takeda Pharmaceutical, and UroGen Pharma.
Debora White
Manager - Marketing
Ph: +1-888-789-6604
Reportstack Market Research

No comments:

Post a Comment